BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 20371119)

  • 21. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
    Nihira K; Ando Y; Yamaguchi T; Kagami Y; Miki Y; Yoshida K
    Cell Death Differ; 2010 Apr; 17(4):689-98. PubMed ID: 19911008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells.
    Hölschermann H; Schuster D; Parviz B; Haberbosch W; Tillmanns H; Muth H
    Atherosclerosis; 2006 Apr; 185(2):240-5. PubMed ID: 16051251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
    Bendinelli P; Matteucci E; Maroni P; Desiderio MA
    Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
    Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
    Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease.
    Suzuki Y; Ichiyama T; Ohsaki A; Hasegawa S; Shiraishi M; Furukawa S
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):134-8. PubMed ID: 19138739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of chroman carboxamide on interleukin-6 expression in response to lipopolysaccharide by preventing nuclear factor-kappaB activation in macrophages.
    Kim BH; Lee KH; Chung EY; Chang YS; Lee H; Lee CK; Min KR; Kim Y
    Eur J Pharmacol; 2006 Aug; 543(1-3):158-65. PubMed ID: 16797005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation.
    De Bosscher K; Schmitz ML; Vanden Berghe W; Plaisance S; Fiers W; Haegeman G
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13504-9. PubMed ID: 9391055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
    Morrison TE; Kenney SC
    Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.
    Janjetovic Z; Tuckey RC; Nguyen MN; Thorpe EM; Slominski AT
    J Cell Physiol; 2010 Apr; 223(1):36-48. PubMed ID: 20020487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
    Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
    Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation.
    Quivy V; Van Lint C
    Biochem Pharmacol; 2004 Sep; 68(6):1221-9. PubMed ID: 15313420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
    Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
    Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
    Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
    Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
    Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
    Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter.
    Gao Z; Chiao P; Zhang X; Zhang X; Lazar MA; Seto E; Young HA; Ye J
    J Biol Chem; 2005 Jun; 280(22):21091-8. PubMed ID: 15811852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aqueous extract of Vitex trifolia L. (Labiatae) inhibits LPS-dependent regulation of inflammatory mediators in RAW 264.7 macrophages through inhibition of Nuclear Factor kappa B translocation and expression.
    Matsui M; Adib-Conquy M; Coste A; Kumar-Roiné S; Pipy B; Laurent D; Pauillac S
    J Ethnopharmacol; 2012 Aug; 143(1):24-32. PubMed ID: 22732725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental study on 1,25(OH)
    Du J; Li R; Yu F; Yang F; Wang J; Chen Q; Wang X; Zhao B; Zhang F
    Oral Dis; 2017 Sep; 23(6):770-778. PubMed ID: 28231625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.